Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
This study has been completed.
Information provided by (Responsible Party):
First received: September 29, 2011
Last updated: January 13, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||February 2015|
|Primary Completion Date:||February 2015 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Received:||January 13, 2016|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Tarantino MD, Bussel JB, Blanchette VS, Despotovic J, Bennett C, Raj A, Williams B, Beam D, Morales J, Rose MJ, Carpenter N, Nie K, Eisen M. Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study. Lancet. 2016 Jul 2;388(10039):45-54. doi: 10.1016/S0140-6736(16)00279-8.